Logo1
CBI - 10th Annual Guidelines for Disseminating Off-Label Information
Mr pencil

How would you like your name to appear on your certificate?



What activities did you attend at the event?
Agreement
By completing this form, you attest that you have participated in all selected activities in thier entirety.
Please rate the following:
Overall quality of the meeting.
The program was relevant to my work.
Content matched stated objectives.
Usefulness of handouts/AV.
Comfort of rooms.
How well did the educational sessions give a balanced view of therapeutic options, including the use of general names?
If you rated any of the above questions with 'fair,' 'poor,' 'disagree' or 'strongly disagree' please explain:
Please rate the expertise of the speakers - Paul J. Silver; Timothy J. Nugent, CPA; Tracy Mastro and Karen Lowney.
Please rate the expertise of the speaker - Mark DeWyngaert.
Please rate the expertise of the speakers - Arnold I. Friede and Stephen Payne.
Please rate the expertise of the speakers - David E Matyas (Moderator), Michael Loucks, John Brownlee, Linda Wawzenski and Ioana Petrou.
Please rate the expertise of the speaker - John Kamp.
Please rate the expertise of the speakers - Jeffrey Spears, Pharm.D and Steve Guymon.
Objective: Practice compliancy in distributing, posting and using medical information.
The above objective has increased my professional knowledge.
The above objective will increase my professional competence.
The above objective will result in performance changes in my professional practice.
Please rate the teaching ability of the speakers - Paul J. Silver; Timothy J. Nugent, CPA; Tracy Mastro and Karen Lowney.
Please rate the teaching ability of the speaker - Mark DeWyngaert.
Please rate the teaching ability of the speakers - Arnold I. Friede and Stephen Payne.
Please rate the teaching ability of the speakers -  David E Matyas (Moderator), Michael Loucks, John Brownlee, Linda Wawzenski and Ioana Petrou.
Please rate the teaching ability of the speaker - John Kamp.
Please rate the teaching ability of the speakers - Jeffrey Spears, Pharm.D and Steve Guymon.
Objective: Define the role of Medical Affairs personnel in the dissemination of information to HCPs and Decision-Making Bodies.
The above objective has increased my professional knowledge.
The above objective will increase my professional competence.
The above objective will result in performance changes in my professional practice.
Please rate the speaker's responsiveness to questions:
Please rate the speaker's responsiveness to questions:
Please rate the speakers' responsiveness to questions:
Please rate the speakers' responsiveness to questions:
Please rate the speaker's responsiveness to questions:
Please rate the speakers' responsiveness to questions:
Objective: Describe the current regulatory, oversight and enforcement environment with regards to off-label information and lessons learned.
The above objective has increased my professional knowledge.
The above objective will increase my professional competence.
The above objective will result in performance changes in my professional practice.

Discuss recent off-label cases.

Appraise the current business risk environment.

Discuss what needs to be done to prepare the organization for a CIA.

Describe how to strengthen MSL interaction with physicians.

Examine Medical Affairs personnel interactions with P&T commimttees and others in managed care.

Discuss FDA Compliance Actions on advertising and promotion.

Discuss lessons learned from the latest off-label indictments and settlements.

Discuss criteria used in recent enforcement actions.

List safeguards to help minimize violations.

Explore areas that should still be considered high risk for enforcement activity, despite the new guidelines for reprint dissemination that FDA proposes.

Identify methods to ensure knowledge of policies and company compliance regulations.

Identify frequency of documentation.

Define the external provider's role and responsibility in auditing.

List some implentation strategies.
Discuss how the FDA Draft Guidance on "Good Reprint Practices" effects MSL activities.
Discuss the political environment as it relates to communicating medical information.
Describe how to participate in the political environment.
Objective: Discuss the impact on industry with regards to the current FDA Draft Guidance on "Good Reprint Practices."
The above objective has increased my professional knowledge.
The above objective will increase my professional competence.
The above objective will result in performance changes in my professional practice.
If you have additional comments regarding the session or speakers, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
Please answer the following:

Do you believe this activity was appropriate for the scope of your professional activities?

Do you believe this activity will result in your ability to improve your practice?
Was the educational content scientifically sound?
Was the educational content free of commercial bias?
If faculty spoke about off-label or investigational use of a product, was that information disclosed to you?
Was the mode of education effective to learning?
If you answered 'No' to any of the above questions, please explain:
Were you solicited by sales personnel in an educational room while you attended this educational activity?
If you answered 'Yes' to the above question, please explain:
What did you learn during this activity that you intend to integrate into your practice?

List any perceived practice "gaps" (educational needs/topics) which you would like to see the focus of future trainings.

Are you interested in basic, intermediate or advanced level trainings?

What barriers might you have that would interfere with implementation of new information learned from this training?

How can this training be improved to impact your competence or practice?

Additional comments:

Mr question